Cargando…
Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants
Phosphatidylinositol 3-kinase, catalytic subunit alpha (PIK3CA) is an oncogene often mutated in colorectal cancer (CRC). The contribution of PIK3CA mutations in acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy is well documented, but their prognostic and predictive value r...
Autores principales: | Ghodsinia, Arman Ali, Lego, J-Ann Marie T., Garcia, Reynaldo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290687/ https://www.ncbi.nlm.nih.gov/pubmed/32365913 http://dx.doi.org/10.3390/cells9051116 |
Ejemplares similares
-
Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer
por: Vatte, Chittibabu, et al.
Publicado: (2019) -
Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer
por: Hao, Yujun, et al.
Publicado: (2022) -
Targeting p85β nuclear translocation for the tumors with PIK3CA helical domain mutations
por: He, Baoyu, et al.
Publicado: (2022) -
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
por: Garay, Joseph P., et al.
Publicado: (2021) -
PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies
por: Tang, Yu, et al.
Publicado: (2020)